Why medical cannabis is still out of patients' reach-an essay by David Nutt.
作者信息
Nutt David
机构信息
Imperial College London, London W12 0NN, UK.
出版信息
BMJ. 2019 May 1;365:l1903. doi: 10.1136/bmj.l1903.
PMID:31043373
Abstract
摘要
相似文献
1
Why medical cannabis is still out of patients' reach-an essay by David Nutt.为何医用大麻仍让患者难以企及——大卫·纳特的一篇文章
BMJ. 2019 May 1;365:l1903. doi: 10.1136/bmj.l1903.
2
Why doctors have a moral imperative to prescribe and support medical cannabis-an essay by David Nutt.为何医生在开具和支持医用大麻处方方面负有道德责任——大卫·纳特的一篇文章
BMJ. 2022 Feb 23;376:o483. doi: 10.1136/bmj.o483.
3
David Nutt: making the medical case for addiction.
Lancet. 2013 Mar 23;381(9871):987. doi: 10.1016/S0140-6736(13)60700-X. Epub 2013 Mar 22.
4
[Cannabis cessation interventions offered to young French users: predictors of follow-up].[为法国年轻使用者提供的大麻戒断干预措施：随访的预测因素]
Encephale. 2012 Apr;38(2):141-8. doi: 10.1016/j.encep.2011.04.007. Epub 2011 Aug 31.
5
Nutt damage.
Lancet. 2010 Feb 27;375(9716):723-4; author reply 724. doi: 10.1016/S0140-6736(10)60301-7.
6
From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of "plum" cannabis flowers to medical marijuana patients in Washington State.从 32 盎司到零：华盛顿州为医疗大麻患者配给一批“李子”大麻花的医疗地理研究。
J Psychoactive Drugs. 2013 Apr-Jun;45(2):141-55. doi: 10.1080/02791072.2013.785835.
7
David Nutt: Champions off-licence prescribing.
BMJ. 2015 May 27;350:h2808. doi: 10.1136/bmj.h2808.
8
"Alcohol alternatives: a goal for psychopharmacology?" by David J. Nutt.
J Psychopharmacol. 2006 May;20(3):327-8, discussion 331. doi: 10.1177/0269881106063043.
9
ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin.2011年欧洲神经精神药理学学会中枢神经系统药物研究未来峰会：大卫·纳特和盖伊·古德温为欧洲神经精神药理学学会撰写的报告
Eur Neuropsychopharmacol. 2011 Jul;21(7):495-9. doi: 10.1016/j.euroneuro.2011.05.004.
10
What You Need to Know About Cannabis - Understanding the Facts Emmett David Nice Graeme What You Need to Know About Cannabis - Understanding the Facts 128pp Jessica Kingsley Publishers 9781843106975 1843106973 [Formula: see text].
Nurs Stand. 2009 Jun 3;23(39):30. doi: 10.7748/ns2009.06.23.39.30.b915.
引用本文的文献
1
An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?医用大麻监管制度评估：英国能吸取哪些经验教训？
Med Cannabis Cannabinoids. 2020 Jan 15;3(1):76-83. doi: 10.1159/000505028. eCollection 2020 Aug.
2
A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.多准则决策分析比较慢性神经性疼痛的药物治疗，包括大麻素和基于大麻的医疗产品。
Cannabis Cannabinoid Res. 2022 Aug;7(4):482-500. doi: 10.1089/can.2020.0129. Epub 2021 Mar 17.
3
Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.开发英国处方大麻的真实世界证据基础：来自 Project Twenty21 的初步发现。
Psychopharmacology (Berl). 2022 May;239(5):1147-1155. doi: 10.1007/s00213-021-05855-2. Epub 2021 May 10.
Zotero 插件